GlassScriptPhysician profile
Michael Bennett Tradewell
NPI 1821550377
$3,456.24
in general payments reported to CMS, 2019-2025
29 companies · $1,927 in 2025
The $1,927 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $534 · 2024: $996 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,207 · Education: $236 · Travel and Lodging: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,206.54 |
| Education | $235.70 |
| Travel and Lodging | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $707.63 | 2023-2025 | Ams 700, Spaceoar Vue System - 10ml, Axonics |
| Astellas Pharma US INC | $445.62 | 2023-2025 | Xtandi |
| Endo USA, INC. | $372.75 | 2024-2025 | Aveed, Xiaflex |
| Axonics, INC. | $324.93 | 2023-2024 | Axonics |
| Procept Biorobotics Corporation | $195.71 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $152.80 | 2024-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $124.27 | 2025 | Erleada |
| Endo Pharmaceuticals INC. | $120.00 | 2023 | Xiaflex |
| Medtronic, INC. | $113.01 | 2024-2025 | Interstim, Altaviva |
| Coloplast Corp | $112.18 | 2024-2025 | |
| Tolmar, INC. | $95.02 | 2024-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $85.31 | 2024 | Prolaris |
| Abbvie INC. | $80.96 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $72.87 | 2025 | Adstiladrin |
| Valencia Technologies Corporation | $70.90 | 2025 | Ecoin Device Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $51.50 | 2024-2025 | Itind System, Gyrus Acmi |
| Immunitybio, INC. | $40.19 | 2024-2025 | |
| Urogen Pharma, INC. | $34.80 | 2025 | |
| Antares Pharma, INC. | $30.35 | 2025 | Xyosted |
| Profound Medical Corp. | $26.24 | 2025 | Tulsa-Pro |
| Laborie Medical Technologies Corp. | $26.18 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Aquarius Lt |
| Sumitomo Pharma America, INC. | $25.70 | 2024 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $24.97 | 2025 | Provenge |
| Pfizer INC. | $24.64 | 2025 | |
| Blue Earth Diagnostics | $23.51 | 2024 | |
| Bluewind Medical | $20.32 | 2025 | Revi |
| Philips North America LLC | $19.53 | 2025 | Oncology Solution |
| Ambu INC. | $19.47 | 2025 | |
| Calyxo, INC. | $14.88 | 2025 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tradewell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.